Vanda Pharmaceuticals (VNDA) Payables (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Payables of $60.6 million in Q1 2026, down 11.24% quarter-over-quarter from $68.3 million in Q4 2025, and up 33.88% year-over-year from $45.3 million in Q1 2025.
Vanda Pharmaceuticals' Payables history runs 17 years deep, the most recent figure standing at $60.6 million for Q1 2026.
- In Q1 2026, Payables rose 33.88% year-over-year to $60.6 million; the TTM figure through Mar 2026 stood at $60.6 million (up 33.88% YoY), while the FY2025 annual figure was $68.3 million, up 74.74% from the prior year.
- Payables came in at $60.6 million for Q1 2026 at Vanda Pharmaceuticals, down from $68.3 million in the prior quarter.
- In the past five years, Payables ranged from a high of $68.3 million in Q4 2025 to a low of $31.9 million in Q2 2023.
- A 5-year average of $45.3 million and a median of $45.3 million in 2025 frame the typical range for Payables.
- Across the five-year window, Payables surged 96.87% in 2022 and slumped 36.44% in 2023, its largest moves.
- Vanda Pharmaceuticals' Payables stood at $45.6 million in 2022, then slipped by 15.57% to $38.5 million in 2023, then climbed by 1.63% to $39.1 million in 2024, then surged by 74.74% to $68.3 million in 2025, then fell by 11.24% to $60.6 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $60.6 million, $68.3 million, and $47.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | 60.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.62 Mn |
| Dec 31, 2025 | 68.30 Mn |
| Sep 30, 2025 | 47.62 Mn |
| Jun 30, 2025 | 57.12 Mn |
| Mar 31, 2025 | 45.28 Mn |
| Dec 31, 2024 | 39.09 Mn |
| Sep 30, 2024 | 39.30 Mn |
| Jun 30, 2024 | 39.60 Mn |
| Mar 31, 2024 | 37.77 Mn |
| Dec 31, 2023 | 38.46 Mn |
| Sep 30, 2023 | 32.60 Mn |
| Jun 30, 2023 | 31.93 Mn |
| Mar 31, 2023 | 35.09 Mn |
| Dec 31, 2022 | 45.55 Mn |
| Sep 30, 2022 | 50.13 Mn |
| Jun 30, 2022 | 50.24 Mn |
| Mar 31, 2022 | 51.39 Mn |
| Dec 31, 2021 | 34.44 Mn |
| Sep 30, 2021 | 31.82 Mn |
| Jun 30, 2021 | 31.79 Mn |
| Mar 31, 2021 | 26.11 Mn |
| Dec 31, 2020 | 31.51 Mn |
| Sep 30, 2020 | 29.09 Mn |
| Jun 30, 2020 | 28.40 Mn |
| Mar 31, 2020 | 26.05 Mn |
| Dec 31, 2019 | 27.59 Mn |
| Sep 30, 2019 | 26.99 Mn |
| Jun 30, 2019 | 29.31 Mn |
| Mar 31, 2019 | 27.42 Mn |
| Dec 31, 2018 | 21.58 Mn |
| Sep 30, 2018 | 19.05 Mn |
| Jun 30, 2018 | 18.56 Mn |
| Mar 31, 2018 | 17.24 Mn |
| Dec 31, 2017 | 20.34 Mn |
| Sep 30, 2017 | 18.92 Mn |
| Jun 30, 2017 | 19.13 Mn |
| Mar 31, 2017 | 18.03 Mn |
| Dec 31, 2016 | 16.20 Mn |
| Sep 30, 2016 | 17.57 Mn |
| Jun 30, 2016 | 17.93 Mn |
| Mar 31, 2016 | 22.66 Mn |
| Dec 31, 2015 | 15.77 Mn |
| Jun 30, 2015 | 1.63 Mn |
| Mar 31, 2015 | 1.49 Mn |
| Dec 31, 2014 | 7.29 Mn |
| Sep 30, 2014 | 547,000.00 |
| Jun 30, 2014 | 248,000.00 |
| Mar 31, 2014 | 953,000.00 |
| Dec 31, 2013 | 661,000.00 |
| Sep 30, 2013 | 369,000.00 |
| Jun 30, 2013 | 1.17 Mn |
| Mar 31, 2013 | 1.11 Mn |
| Dec 31, 2012 | 287,000.00 |
| Sep 30, 2012 | 1.09 Mn |
| Jun 30, 2012 | 1.69 Mn |
| Mar 31, 2012 | 780,000.00 |
| Dec 31, 2011 | 996,000.00 |
| Sep 30, 2011 | 1.33 Mn |
| Jun 30, 2011 | 1.34 Mn |
| Dec 31, 2010 | 648,000.00 |